Reduction of tumour blood flow with KB-R8498 potentiates the response of tumours to hyperthermia

International Journal of Hyperthermia

Volumn 15, Issue 1, 1999, Pages 1-6

  Shakil, A ^a   Ogawa, A ^a   Griffin, R J ^a   Song, C W ^a  

^a Radiation Biology Section   (United States)

Author keywords

Hyperthermia; KB R8498; Tumour blood flow

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERTHERMIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; TEMPERATURE; TIME; TUMOR; TUMOR BLOOD FLOW; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; PIPERAZINES; QUINAZOLINES;

EID: 0032990663     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.1080/026567399285800     Document Type: Article

References (14)

1. HASEGAWA, T., and SONG, C. W., 1991, Effect of hydralazine on the blood flow in tumors and normal tissues in rats. International Journal of Radiation Oncology, Biology and Physics, 20, 1001-1007.
2. HIRST, D. G., HIRST, V. K., SHAFFI, K. M., PRISE, V. E., and JOINER, B, 1991, The influence of vasoactive agents on the perfusion of tumors growing in three sites in the mouse. International Journal of Radiation Oncology, Biology and Physics, 60, 211-218.
3. HONESS, D. J., and BLEEHEN, N. M., 1991, Effects of two tumor blood flow modifiers, hydralazine and flavone acetic acid, on KHT tumors and normal tissues in mice. International Journal of Radiation Oncology, Biology and Physics, 60, 249-253.
4. LIN, J.-C., and SONG, C. W., 1990, Effect of hydralazine on blood flow in RIF-1 tumors and normal tissues of mice. Radiation Research, 124, 171-177.
5. PETERS, C. E., TROTTER, M. J., and CHAPLIN, D. J., 1991, Early spatial and temporal changes in tumor perfusion after administration of flavone acetic acid. International Journal of Radiation Oncology, Biology and Physics, 60, 341-348.
6. RHEE, J. G., KIM, T. H., LEVITT, S. H., and SONG, C. W., 1984, Changes in acidity in mouse tumor by hyperthermia. International Journal of Radiation Oncology, Biology and Physics, 10, 393-399.
7. SAPIRSTEIN, L. A., 1958, Regional blood flow by fractional distribution of indicators. American Journal of Physiology, 193, 161-168.
8. SEKIDA, T., MATSUI, T., MATSUGI, W., IDOGAWA, H., WARASHINA, H., IKEDA, Y., and OHASHI, M., 1997a, A novel anti-tumor agent: Tumor blood flow inhibitor, KB-R8498. Proceedings of the American Association of Cancer Research, 38, 217 (Abstract 1465).
9. SEKIDA, T., OYAMA, M., MATSUGI, W., MATSUI, T., HARADA, K., KOTERA, Y., and OHASHI, M., 1997b, A novel anti-tumor agent: Mode of action of tumor blood flow inhibitor, KB-R8498. Proceedings of the American Association of Cancer Research, 38, 218 (Abstract 1467).
10. SONG, C. W., 1984, Effect of local hyperthermia in blood flow and microenvironment: A review. Cancer Research, 44 (suppl.), S4721-S4730.
11. SONG, C. W., LIN, J.-C., CHELSTROM, L. M., and LEVITT, S. H., 1989. The kinetics of vascular thermotolerance in SCK tumors of A/J mice. International Journal of Radiation Oncology, Biology and Physics, 17, 799-802.
12. 1 agonists. International Journal of Radiation Oncology, Biology and Physics, 37, 1125-1131.
13. 2 agonists by tumour-feeding arterioles in mice: consequences for tumour growth. International Journal of Radiation Biology, 60, 237-241.
14. VAUPEL, P., OKUNIEFF, P., and KLUGE, M., 1989, Response of tumor red blood cell flux to hyperthermia and/or hyperglycemia. International Journal of Hyperthermia, 5, 199-210.